IRON: SEC Form 144 filed by Disc Medicine Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for IRON
Across the 26 sessions after earlier IRON headlines, the stock closed higher 13 times and lower 13 times, with a median move of 1.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | IRON | SPY |
|---|---|---|---|
| Oct 20, 2026 | Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants | +0.7% | +0.3% |
| Oct 19, 2026 | Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)and 1 other headline that session | +38.9% | +0.4% |
| Sep 2, 2026 | Disc Medicine to Participate in Upcoming Investor Conferences | +1.8% | +0.4% |
| Sep 1, 2026 | Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting | +0.0% | -0.7% |
| Jul 30, 2026 | Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update | +7.5% | +1.7% |
| Jun 12, 2026 | Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting | -0.1% | +0.5% |
Quantisnow market dataNASDAQ
IRON
Disc Medicine Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for IRON
Full IRON profile on Quantisnow Follow IRON and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time